Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
m |
|||
| Line 63: | Line 63: | ||
| [[Media:002.QIBA SPECT Ioflupane Profile v2.0.2019 10 15.pdf | SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15]] | | [[Media:002.QIBA SPECT Ioflupane Profile v2.0.2019 10 15.pdf | SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15]] | ||
| Public Comment | | Public Comment | ||
| − | | | + | | 12.31.2016 |
| − | | | + | | No public comment for v 2.0; it is an update of v 1.0 [[Media: x | Public Comment Resolutions 2016-12-31]] |
|- | |- | ||
| [[Media:QIBA_99mTC SPECT 2020-05-12.pdf| 99mTC SPECT 2020-05-12]] | | [[Media:QIBA_99mTC SPECT 2020-05-12.pdf| 99mTC SPECT 2020-05-12]] | ||
Revision as of 18:48, 10 June 2020
Comments received during Public Comment, Technical Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.